SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-017344
Filing Date
2020-06-22
Accepted
2020-06-22 16:01:03
Documents
2
Period of Report
2020-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1516
2 EX-24 DOCUMENT attachment1.htm EX-24 3447
  Complete submission text file 0000899243-20-017344.txt   6272
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Issuer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences

Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Toft Robin (Reporting) CIK: 0001815565 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36571 | Film No.: 20978813